Trial · NCT07898176
e-Perinatal Butterfly: An Embedded Study for Parents Experiencing Perinatal Loss
NCT07898176, Not applicable, Not yet recruiting, University of Seville
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. e-Perinatal Butterfly: An Embedded Study for Parents Experiencing Perinatal Loss. Trials, record NCT07898176. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07898176
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- e-Perinatal Butterfly: An Embedded Study for Parents Experiencing Perinatal Loss
- NCT number
- NCT07898176
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 60 participants, estimated
- Lead sponsor
- University of Seville
- Conditions
- Depressive Symptoms, Perinatal Loss, Perinatal Grief, Anxiety Symptoms
- Interventions
- e-Perinatal Butterfly, Standard routine maternal care
- First posted
- 2026-10-27
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Feasibility of the intervention | Measured at enrollment and postintervention (3 months after enrollment) | Calculation of participation rate, recruitment rate, and retention rate (follow-up rate) at all assessment points. Assessment method: Registration and follow-up records. |
| Primary | Early acceptability | Measured at enrollment | Number of eligible women and partners who agree to participate. Assessment method: Login to e-Perinatal Butterfly. |
| Primary | Final acceptability | Measured at postintervention (3 months after enrollment) | Evaluation of how appropriate, satisfactory, and feasible the intervention is after its implementation. Assessment method: Surveys and semi-structured interviews based on the Normalization Process Theory. |
| Secondary | Final appropriateness | Measured at postintervention (3 months after enrollment) | Suitability and relevance of the intervention for the target population and context. Assessment method: Semi-structured interviews based on the Normalization Process Theory. |
| Secondary | Depressive symptoms | Measured at enrollment and postintervention (3 months after enrollment) | Changes in depressive symptoms. Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms. |
| Secondary | Anxiety symptoms | Measured at enrollment and postintervention (3 months after enrollment) | Changes in anxiety symptoms. Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms. |
| Secondary | Perinatal grief | Measured at enrolment and postintervention (3 months after enrollment) | Measures the intensity and impact of grief following perinatal loss. Assessment method: The Perinatal Grief Scale, a 16-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating a higher intensity and impact of grief on the psychological health. |
| Other | App quality | Measured at postintervention (3 months after enrollment) | Objective and subjective quality, and the perceived impact of the application. Assessment method: The User Version of the Mobile Application Rating Scale (u-MARS), a 26-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating better app quality. |
| Other | Basic psychological needs | Measured at enrollment and postintervention (3 months after enrollment) | Measures the satisfaction and frustration of basic psychological needs. Assessment method: The Basic Psychological Need Satisfaction and Frustration Scale - Short Form (BPNSFS), a 12-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating a higher need satisfaction (i.e., need satisfaction subscale) or a higher need frustration (i.e., need frustration subscale). |
| Other | Comparative Symptom Trajectories of Depression and Anxiety | Assessments aligned with primary study e-Perinatal: baseline, endpoints at 12 and 18 months post-Estimated Date of Delivery (EDD) | Differences in mean change scores for depression and anxiety between bereaved mothers and partners using the Butterfly module and non-bereaved participants in the main e-Perinatal cohort. Changes in depressive symptoms. Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms. Changes in anxiety symptoms. Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07898176
GET https://conductscience.org/api/trials/v1/NCT07898176/registered